Jennison Associates LLC Raises Position in Enterprise Products Partners LP (EPD)

Lloyd Doyle
September 21, 2017

Avalon Advisors Llc sold 290,287 shares as the company's stock declined 6.06% while stock markets rallied. The company has market cap of $703.33 million. It closed at $133.22 lastly. Sanford C. Bernstein reissued an "outperform" recommendation on stocks of Enterprise Products Partners in a study analysis published on early Thur, Aug 10th. Reynders Mcveigh holds 0.09% of its portfolio in Enterprise Products Partners L.P. (NYSE:EPD) for 22,996 shares. KKR & Co. L.P. analysts have any power to influence the stock's share price, the highest price target set for KKR is $27. Enterprise Products Partners L.P. (EPD) now trades with a market capitalization of $56.00 Billion. Akzo Nobel N.V. (ADR) (OTCMKTS:AKZOY) has 0.00% since September 21, 2016 and is. It has underperformed by 16.88% the S&P500. Therefore 67% are positive. Of the analysts surveyed by Reuters that track Enterprise Products Partners L.P. 1 of them rate its stock a hold. BMO Capital Markets maintained it with "Buy" rating and $3300 target in Monday, June 5 report. Morgan Stanley raised Enterprise Products Partners L.P. from an "equal weight" rating to an "overweight" rating and boosted their price target for the company from $26.37 to $26.50 in a research report on Thursday, June 15th. Canaccord Genuity has "Buy" rating and $2300 target.

Enterprise Products Partners L.P. (NYSE:EPD) has a market cap of $56 billion and over the last 12 months, EPD has declined by -2.48%. The stock has "Buy" rating by Citigroup on Tuesday, April 19. Obermeyer Wood Invest Counsel Lllp has invested 0.52% in Enterprise Products Partners L.P. (NYSE:EPD). The stock has "Buy" rating by Wunderlich on Wednesday, August 31. The firm earned "Hold" rating on Wednesday, January 25 by TD Securities. As per Monday, October 10, the company rating was maintained by Deutsche Bank. The firm has "Sector Outperform" rating by Howard Weil given on Wednesday, January 6. Finally, Scotiabank set a $33.00 target price on shares of Enterprise Products Partners L.P. and gave the stock a "buy" rating in a research note on Friday, July 21st. The stock of Enterprise Products Partners L.P. (NYSE:EPD) earned "Buy" rating by Mizuho on Friday, September 30. It also reduced its holding in Portfolio Recovery As. Asset Advsr Corp holds 0% or 1,000 shares.

Investors sentiment decreased to 0.99 in 2017 Q2. When we look at the Volatility of the company, Week Volatility is at 0.90% whereas Month Volatility is at 1.53%. It fall, as 54 investors sold EPD shares while 250 reduced holdings. 16 funds opened positions while 45 raised stakes. 742.88 million shares or 1.01% more from 735.46 million shares in 2016Q3 were reported. Looking at the stock's movement on the chart, Enterprise Products Partners L.P. recorded a 52-week high of $30.25.

Enterprise Products Partners LP's Williams Percent Range or 14 day Williams %R now sits at -88.04. Paragon Capital Mgmt Limited reported 15,290 shares. Bsw Wealth Ptnrs has 0.1% invested in Enterprise Products Partners L.P. (NYSE:EPD) for 7,763 shares. Palisade Asset Ltd Limited Liability Company, a Minnesota-based fund reported 9,920 shares. The company has a net profit margin of 10.20% and is more profitable than the average Independent Oil & Gas player.

Ratings analysis reveals 96% of Enterprise Products Partners LP's analysts are positive.


09/16/2016 - Evercore ISI began new coverage on Enterprise Products Partners L.P. giving the company a "buy" rating.

Shares of Enterprise Products Partners L.P. (NYSE:EPD) experienced a change of -0.38% in final minutes of trading Tuesday. 8,290 were reported by Budros Ruhlin Roe. Virtu Ltd stated it has 288,661 shares. Axa has 20,000 shares. Solaris Asset Lc reported 0.23% stake.

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Fool.com which released: "Pfizer Punches Back at Johnson & Johnson in Prostate Cancer" on September 15, 2017, also Prnewswire.com with their article: "Johnson & Johnson Talcum Powder Lawsuits Mount, As Ovarian Cancer Claims ..." published on September 20, 2017, Fiercebiotech.com published: "China's WuXi, Johnson & Johnson-backed XW Labs lands $17.5M series B" on September 20, 2017. (NYSE:EPD) opened at 25.99 on Thursday. They expect $0.32 EPS, up 6.67% or $0.02 from last year's $0.3 per share. EPD generated revenue of $6.36 Billion in the same quarter, one year ago. Institutional investors own 38.00% stake in the company while Beta factor, which is used to measure riskiness of the security, was 0.91.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Other reports by Iphone Fresh

Discuss This Article

FOLLOW OUR NEWSPAPER